Search these posts for articles, publications, research studies & discussions relevant to Phoenix Technology Group products.

Research Blog

2019

ARVO 2019: Frogs, Glue and CNV

Another ARVO passed by in a blur of research, scientific discussions, and seeing science friends. If you came by our booth, thank you for swinging by to chat with the Phoenix team. If you didn’t get a chance, please let me know if you have any questions about the Micron system and look for our

2019

Industry Expert Leslie MacKeen Joins Phoenix Technology Group as Product Manager

MacKeen brings 28 years of imaging expertise in ophthalmic research and pediatric ophthalmic imaging and will drive product initiatives across both Research and Clinical imaging solutions Pleasanton, CA, USA, April 10, 2019  – Today, Phoenix Technology Group (Phoenix), a leading provider of advanced ophthalmic imaging solutions for researchers and clinicians, announces Leslie MacKeen has joined

2019

Phoenix MICRON CNV System used to test a novel treatment for age-related macular degeneration

In their paper, “Suppression of Choroidal Neovascularization by AAV-Based Dual-Acting Antiangiogenic Gene Therapy,” Askou et al develop an adeno-associated virus (AAV) treatment for age-related macular degeneration. Beautiful fluorescent fundoscopy performed with the Phoenix MICRON validated the success of the subretinal AAV injection, while precise choroidal neovascularization (CNV) induced by Phoenix laser burns confirmed that the

2019

Corneal Thickness Analysis using OCT

Corneal images taken with the Phoenix Micron IV OCT used for thickness analysis King et al, a consortium of researchers at a range of institutions, recently used the Phoenix Micron IV OCT to examine corneal thickness in their article, “Genomic locus modulating corneal thickness in the mouse identifies POU6F2 as a potential risk of developing

2019

Characterizing a mutant rat strain with the Phoenix Micron OCT and Ganzfeld ERG

Monai et al characterized the longitudinal retinal degeneration of a rat model of retinitis pigmentosa using the Phoenix Micron OCT to examine retinal layers in live rats and the full field Ganzfeld ERG to test function. The rats have one of the mutations, P23H, that cause retinitis pigmentosa in humans, and are specifically a very

2018

Fundus and OCT imaging shows that smart phone-like blue light exposure leads to retinal disruption in rats

Researchers Lin et al at Taipei Medical University shared an alarming finding that blue light, similar to that emitted by smart phones, can lead to retinal disruption in rats. They used the Phoenix Technology Group’s Phoenix MICRON fundus camera and the image-guided OCT to demonstrate blood vessel leakage and retinal thinning after intermittent blue light

1 2 3 4